Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biodesix, Inc. - Common Stock
(NQ:
BDSX
)
0.6183
-0.0117 (-1.86%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Stocks That Hit 52-Week Lows On Thursday
March 24, 2022
On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...
Via
Benzinga
Recap: Biodesix Q4 Earnings
March 14, 2022
Biodesix (NASDAQ:BDSX) reported its Q4 earnings results on Monday, March 14, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Preview: Biodesix's Earnings
March 11, 2022
Biodesix (NASDAQ:BDSX) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Biodesix's Return On Capital Employed Insights
March 15, 2022
Biodesix (NASDAQ:BDSX) brought in sales totaling $7.22 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.36%, resulting in a loss of $13...
Via
Benzinga
Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights
March 14, 2022
From
Biodesix
Via
Business Wire
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022
February 28, 2022
From
Biodesix, Inc.
Via
Business Wire
Earnings Scheduled For March 14, 2022
March 14, 2022
Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...
Via
Benzinga
Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022
February 22, 2022
From
Biodesix, Inc.
Via
Business Wire
73 Biggest Movers From Yesterday
February 23, 2022
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...
Via
Benzinga
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited)
February 14, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2022
From
Biodesix, Inc.
Via
Business Wire
64 Biggest Movers From Yesterday
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
PierianDx and Biodesix Partner to Advance Lung Cancer Diagnostics
January 19, 2022
From
PierianDx
Via
Business Wire
Biodesix Announces the Launch of its GeneStrat NGS™ Test and the IQLung™ Testing Strategy with Unprecedented Time to Results
January 18, 2022
From
Biodesix, Inc.
Via
Business Wire
Insider Weekends: Co-Founder Of EverQuote Acquires $1.45 Million Worth Of Stock
January 09, 2022
Reviewing the list of companies that were at a new 52 week high and the ones that had hit a fresh 52 week low last week, I was struck by just how many of the companies in the 52...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...
Via
Benzinga
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
January 04, 2022
From
Biodesix, Inc.
Via
Business Wire
40 Biggest Movers From Friday
January 03, 2022
Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
December 23, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors
December 08, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer
November 18, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer
December 01, 2021
From
Biodesix
Via
Business Wire
Biodesix, Inc. (BDSX) Q3 2021 Earnings Call Transcript
November 16, 2021
BDSX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biodesix Announces Third Quarter 2021 Results and Highlights
November 15, 2021
From
Biodesix, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:
Via
Benzinga
Biodesix to Present Data Supporting Proteomic-Based Immunotherapy Diagnostic Tests and AI Explainability in Diagnostic Tests at Society for Immunotherapy of Cancer Annual Meeting
November 12, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 11, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021
November 01, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting
October 13, 2021
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.